Lindbrook Capital »

Biosante Pharmaceuticals shares owned by Lindbrook Capital

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Lindbrook Capital from 13F filings

Historical chart of Lindbrook Capital investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by Lindbrook Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by Lindbrook Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.5k 117 55.14
2023-09-30 $6.8k 117 58.06
2023-06-30 $6.3k 117 53.83
2023-03-31 $4.6k 117 39.72
2022-12-31 $5.0k 125 40.23
2022-09-30 $4.0k 125 32.00
2022-06-30 $4.0k 125 32.00
2022-03-31 $3.0k 110 27.27
2019-06-30 $16k 200 80.00